Nutex Health (NUTX) CEO exercises RSUs, retains large share stake

Rhea-AI Filing Summary

Nutex Health Inc. CEO Thomas T. Vo reported routine equity compensation activity involving restricted stock units and common shares. Previously granted RSUs converted into 8,334 shares of common stock, and 3,017 of those shares were delivered to satisfy tax withholding obligations rather than sold in an open-market trade.

After these transactions, entities he owns and controls held 1,843,196 common shares, and his direct holdings included 19,524 restricted stock units. He was also granted 4,841 new RSUs that vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Insider Trade Summary

4,841 shares exercised/converted

Mixed 3 txns

Insider Vo Thomas T.

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	4,841	$0.00	--
Exercise	Common Stock	8,334	$0.00	--
Tax Withholding	Common Stock	3,017	$86.2224	$260K

Holdings After Transaction: Restricted Stock Units — 19,524 shares (Direct); Common Stock — 1,846,213 shares (Indirect, See note (4))

Footnotes (1)

1. Restricted stock units convert into common stock on a one-for-one basis. Of the 8,334 shares issued subsequent to vesting, 3,017 shares were sold to cover tax withholding obligations. On March 11, 2026, the Reporting Person was granted 4,841 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 1,840,898 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 23,914 of the securities of the registrant reported herein.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vo Thomas T.

(Last) (First) (Middle)

1776 YORKTOWN STREET

(Street)

HOUSTON TX 77056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		M		8,334(1)	A	$0(1)	1,846,213	I	See note (4)(4)
Common Stock	03/10/2026		F		3,017(2)	D	$86.2224	1,843,196	I	See note (4)(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	03/10/2026		M		4,841(1)		03/01/2027(3)	03/01/2029(3)	Common Stock	4,841	$0	19,524	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. Of the 8,334 shares issued subsequent to vesting, 3,017 shares were sold to cover tax withholding obligations.

3. On March 11, 2026, the Reporting Person was granted 4,841 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

4. Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 1,840,898 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 23,914 of the securities of the registrant reported herein.

	/s/ Thomas Vo	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Nutex Health (NUTX) disclose for CEO Thomas Vo?

Nutex Health reported that CEO Thomas Vo had restricted stock units convert into 8,334 common shares, with part used for tax withholding. The remaining shares increased indirect ownership through entities he controls, reflecting routine equity compensation rather than discretionary open-market buying or selling.

Were Nutex Health CEO Thomas Vo’s Form 4 transactions open-market stock sales?

No, the Form 4 shows shares delivered to cover tax withholding obligations, not open-market sales. Of 8,334 shares issued after vesting, 3,017 were used to satisfy taxes, making the activity compensation-related rather than a discretionary sale decision.

How many Nutex Health shares are indirectly owned through entities associated with Thomas Vo?

Following the reported transactions, entities controlled by Thomas Vo held 1,843,196 Nutex Health common shares. These include holdings by Micro Hospital Holding LLC and Vo Family Limited Partnership, giving him investment and voting control over a large indirect ownership position in the company.

What new equity award did Nutex Health grant to CEO Thomas Vo?

Thomas Vo was granted 4,841 restricted stock units that vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. These RSUs represent additional future equity compensation tied to his continued service with Nutex Health.

How did the Nutex Health Form 4 affect Thomas Vo’s direct restricted stock unit holdings?

After the restricted stock unit conversion, Thomas Vo directly held 19,524 RSUs. These units represent rights to receive Nutex Health common shares in the future, separate from the large block of common stock held indirectly through entities he owns and controls.

What does transaction code F mean in Nutex Health CEO’s Form 4?

Transaction code F indicates shares were withheld or delivered to pay exercise price or tax liability. In this filing, 3,017 Nutex Health shares were used to cover tax withholding, showing a mechanical tax event rather than a voluntary open-market sale by the CEO.